CClinicalTrials.gg
CompletedNCT00737178Updated Sep 19, 2014Results posted

Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion

A Phase 4 interventional study of CuT380A in Contraception, sponsored by Columbia University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-09-19.

Sponsored by Columbia University · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
156
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

After medication abortion, women may quickly become pregnant again and therefore need an effective birth control method right away. Intrauterine devices (IUDs) are very effective for preventing pregnancy. IUDs are usually placed more than a month after abortion. This study will randomly assign women having a medication abortion to two groups, either having the IUD inserted one week after medication abortion or having the IUD inserted more than four weeks later. Women will be followed for six months to compare how many return for IUD placement in the two groups, how many are using the IUD after six months, experience with pain, bleeding, and cramping, how easy or difficult it is to insert the IUD, how many IUDs are expelled or removed, and how many women are using any birth control six months after the abortion.

Read the detailed description

Women presenting for medication abortion are highly motivated to initiate contraception and are also at high risk for repeat pregnancy. Intrauterine devices (IUDs) are among the most effective reversible methods. IUD insertion is routinely planned for at least four weeks after medication abortion. This leaves women vulnerable to pregnancy while waiting for IUD placement, and many will not return for this visit. While immediate IUD insertion after surgical abortion is known to be safe and effective, it has not been studied after medication abortion.

This study will recruit women undergoing medication abortion at Special Gynecology Services who desire an IUD for contraception. Women will be randomized to two groups: immediate insertion of the copper IUD at the routine one week follow up visit, or delayed insertion of the copper IUD at least four weeks after the medication abortion.

The primary objective of this study is to compare six month IUD prevalence between the immediate and delayed IUD insertion groups. Secondary outcomes include comparison of IUD insertion rates, continuation rates, expulsion and removal rates, and use of any contraception at six months. Pain experienced during insertion and provider ease of insertion will be recorded. A diary collected for four weeks following medication abortion will reveal the impact of early IUD placement on bleeding and cramping. Lastly, we will correlate endometrial stripe thickness and IUD position to outcomes of interest: continuation, expulsion, and removal rates.

02

Conditions studied

  • Contraception

Keywords

  • IUD
  • Intrauterine device
  • Intrauterine contraception
  • Medication abortion
  • Medical abortion
03

In context

Lead sponsor

Columbia University is the lead sponsor of 1,103 studies on the registry; 193 are open to participants now.

Of its 172 completed or terminated interventional studies of FDA-regulated products, 142 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Undergoing medication abortion
  • 18 or older
  • Desires IUD as birth control method for a minimum of six months
  • Speaks Spanish or English
  • Has a working phone number or pager
  • Is willing to attend visits and will be in the area for next six months
  • Has signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Chlamydia, gonorrhea, or pelvic inflammatory disease within the past three months
  • Known bleeding diathesis including anti-coagulation
  • Uterine abnormality including sub-mucous myomas that significantly distort the uterine cavity
  • Current cervical, uterine, or ovarian malignancy
  • high-grade squamous intraepithelial lesion on most recent pap
  • IUD insertion contraindicated by the World Health Organization's Medical Eligibility Criteria for Contraceptive Use (category 3 or 4)
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
156 participants (actual)

Study arms

  • Active comparator
    Immediate IUD insertion

    Insertion of CuT380A at the routine medication abortion follow-up visit one week after initiation of a medication abortion

    Device: CuT380A

  • Active comparator
    Delayed IUD insertion

    Insertion of CuT380A four to six weeks after initiation of a medication abortion

    Device: CuT380A

Interventions

  • DeviceCuT380A

    Comparison of different timing of IUD insertion

    Also known as: IUD, Copper T

06

What researchers measure

Primary outcomes

  1. Use of the IUD for Contraception at Six Months

    Six months after enrollment, we determined whether or not women were using the IUD through in-person exit interviews and phone interviews. This was an intention to treat analysis, comparing the proportion of women using the IUD based on their group assignment (immediate or delayed).

    Time frame: 6 months

Secondary outcomes

  1. Insertion Rates

    Insertion rates are the proportion of women in each allocation group (immediate, delayed) who ultimately had the IUD inserted within the 6 month study period.

    Time frame: By six months after medication abortion

  2. Expulsion and Removal Rates

    Expulsion rates were defined as the number of IUDs expelled from the uterus among participants who had the IUD inserted during the study. Removal rates were defined as the number of IUDs that were electively removed by participant request among participants who had the IUD inserted during the study.

    Time frame: Within six months of medication abortion

07

Results

Posted Sep 19, 2014

Participant flow

Women presenting to Columbia University's Special Gynecology Services for medication abortion will receive comprehensive contraceptive counseling. Those interested in the Intrauterine Device (IUD) for contraception will be offered study participation. Those who accept enrollment in the study and sign consent will be randomized into 1 of 2 groups.

Participant flow — Overall Study
MilestoneImmediate IUD InsertionDelayed IUD Insertion
Started7185
Completed6676
Not completed59

Outcome measures

SecondaryInsertion Rates

Insertion rates are the proportion of women in each allocation group (immediate, delayed) who ultimately had the IUD inserted within the 6 month study period.

Time frame:
By six months after medication abortion
Reported as:
Number · participants
Insertion Rates
participantsImmediate IUD InsertionDelayed IUD Insertion
Insertion Rates6965
Statistical analysis
  • Immediate IUD Insertion vs Delayed IUD Insertion · Chi-squared · p = <.01
SecondaryExpulsion and Removal Rates

Expulsion rates were defined as the number of IUDs expelled from the uterus among participants who had the IUD inserted during the study. Removal rates were defined as the number of IUDs that were electively removed by participant request among participants who had the IUD inserted during the study.

Time frame:
Within six months of medication abortion
Reported as:
Number · participants
Expulsion and Removal Rates
participantsImmediate IUD InsertionDelayed IUD Insertion
Expulsions87
Removals105
PrimaryUse of the IUD for Contraception at Six Months

Six months after enrollment, we determined whether or not women were using the IUD through in-person exit interviews and phone interviews. This was an intention to treat analysis, comparing the proportion of women using the IUD based on their group assignment (immediate or delayed).

Time frame:
6 months
Reported as:
Number · participants
Use of the IUD for Contraception at Six Months
participantsImmediate IUD InsertionDelayed IUD Insertion
Use of the IUD for Contraception at Six Months4951
Statistical analysis
  • Immediate IUD Insertion vs Delayed IUD Insertion · Chi-squared · p = 0.24

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Immediate IUD Insertion—0/71 (0%)0/71 (0%)
Delayed IUD Insertion—0/85 (0%)0/85 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Immediate IUD InsertionDelayed IUD InsertionTotal
<=18 years000
Between 18 and 65 years7185156
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Immediate IUD InsertionDelayed IUD InsertionTotal
Female7185156
Male000
Region of Enrollment
Region of Enrollment(participants)Immediate IUD InsertionDelayed IUD InsertionTotal
United States7185156
08

Study locations

1 site
  • Special Gynecology Services
    New York, New York 10032, United States
09

References and documents

Publications

  • Shimoni N, Davis A, Ramos ME, Rosario L, Westhoff C. Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial. Obstet Gynecol. 2011 Sep;118(3):623-628. doi: 10.1097/AOG.0b013e31822ade67. PubMed 21860292 ↗
  • Shimoni N, Davis A, Westhoff C. Can ultrasound predict IUD expulsion after medical abortion? Contraception. 2014 May;89(5):434-9. doi: 10.1016/j.contraception.2014.01.006. Epub 2014 Jan 18. PubMed 24560483 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00737178
Lead sponsor
Columbia University
Responsible party
Anne Davis (Associate Professor of OBGYN, Family Planning, Columbia University) — Principal investigator
First posted
Aug 18, 2008
Start date
Jul 2008
Primary completion
Oct 2009
Completion
Aug 2011
Results posted
Sep 19, 2014
Last update
Sep 19, 2014

Study contacts

Anne Davis, MD MPH
principal investigator · Columbia University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion